Skip to main content
TDOC
NYSE Life Sciences

Teladoc Health第一季度收入下降2%,BetterHelp板块收入下降9%,重申预测

feedReported by Reuters
Sentiment info
Negative
Importance info
7
Price
$5.64
Mkt Cap
$1.074B
52W Low
$4.4
52W High
$9.77
Market data snapshot near publication time

summarizeSummary

Teladoc Health报告称,第一季度收入同比下降2%,其BetterHelp板块收入下降9%,付费用户数量减少。这延续了公司在10-K报告中之前观察到的收入下降和用户指标下滑趋势。尽管公司略高于分析师对第一季度收入和调整后EBITDA的预期,并重申了全年财务预测,但其关键的BetterHelp板块持续收缩对其增长轨迹提出了一项重大挑战。交易者将监测未来报告中这些核心板块的稳定或逆转迹象。

在该公告发布时,TDOC的交易价格为$5.64,交易所为NYSE,所属行业为Life Sciences,市值约为$10.7亿。 52周交易区间为$4.40至$9.77。 这则新闻被评估为消极市场情绪,重要性评分为7/10。 来源:Reuters。


show_chartPrice Chart

Share this article

Copied!

feed TDOC - Latest Insights

TDOC
Apr 29, 2026, 4:53 PM EDT
Source: Reuters
Importance Score:
7
TDOC
Apr 07, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
7
TDOC
Mar 31, 2026, 5:19 PM EDT
Source: Reuters
Importance Score:
9
TDOC
Mar 30, 2026, 5:32 PM EDT
Filing Type: 8-K
Importance Score:
8
TDOC
Feb 26, 2026, 11:07 AM EST
Filing Type: 10-K
Importance Score:
7
TDOC
Feb 25, 2026, 4:04 PM EST
Filing Type: 8-K
Importance Score:
7
TDOC
Feb 18, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
7